Lilly Inks R&D Deal With Indian Firm Potentially Worth $100 Million

Lilly's research and development agreement with India-based Nicholas Piramal India Limited gives the Indian firm the potential to earn $100 million in milestones and call-back payments, the firms said Jan. 12